Abstract:Data obtained from neonatally treated rats are fairly consistent. However, there is disagreement as to whether mechanical and thermal nociceptive thresholds are elevated or unchanged in this group. There are at least two major areas of disagreement in adult animal capsaicin research. Behavioral data are extremely variable. The thermal nociceptive threshold after systemic capsaicin has been reported to be both raised and lowered. After intrathecal capsaicin injection, the thermal nociceptive threshold was reported raised, but onset and duration of responses varied and some animals exhibited no changes. Capsaicin application to peripheral nerve, however, drastically increased thermal threshold. Mechanical pain threshold has been reported both increased and unchanged after systemic capsaicin treatment and unchanged after intrathecal injection. Obviously, capsaicin's effects upon pain perception are not fully understood. Although lower on the phylogenetic scale than many mammals, rodents exhibit complex individualistic behavior. Lower vertebrates may eventually provide more simple behavioral models for pain tolerance.Investigators also disagree as to whether C fibres can conduct action potentials after local capsaicin application. C fibre conduction was reported unaffected by capsaicin in an acute preparation and for 13–21 days after treatment. On the other hand, C fibre compound action potentials have been reported diminished for up to 2 h after capsaicin application. Additional conduction impairment studies will be useful in comparing peripheral and intrathecal capsaicin application.There is general agreement that, allowing for variation in dosages and route of administration, capsaicin causes central and peripheral C fibre damage, though never as extensive in adults as in neonates. Neonatal capsaicin treatment (always s.c.) results in destruction of C and some Aδ fibres and their central terminals. Capsaicin causes degeneration of C terminals in the adult CNS only when applied centrally.In both neonates and adults, s.c. capsaicin depletes the putative ‘pain’ peptide neurotransmitter, SP, from peripheral and sensory neurons and the tissues they innervate but not from the gut. Capsaicin-induced SP depletion in neonates is permanent. Systemic administration to adult depleted SP from much the same areas as observed in neonates, but all areas but the medulla exhibited a slow, regional recovery.Intraventricular injection of capsaicin depleted SP in the adult medulla only, while other SP-containing areas affected by systemic injection remained intact. Intranigral capsaicin injection had no effect on SP content but depleted 5-HT and its metabolite, 5-HIAA, and dopamine metabolites. Direct application of capsaicin to the sciatic nerve may block axonal peptide transport in sensory C fibres but not in motor fibres.In neonates, capsaicin depleted peptide markers of primary afferents, i.e., SRIF, VIP, CCK, FRAP, GABA and opiate receptors from the spinal cord and/or DRG. Systemic administration to adults depleted SRIF and FRAP in the dorsal spinal cord but not opiate receptors or glutamic acid decarboxylase (GAD) activity. Probably because of capsaicin-induced structural and biochemical alterations, spinal, medullary, and peripheral neurons become at least temporarily less responsive, although not uniformly so.Neonatal capsaicin treatment abolished the C fibre mediated neurogenic oedema response to injury or irritation. Subcutaneous administration or direct (but not intrathecal) application of capsaicin to peripheral nerve temporarily blocked neurogenic oedema in adults. On a gross scale, pharmacological tests employing capsaicin are aimed at identifying the receptors it affects to explain complex visceral reflex mechanisms. Neurophysiological tests are more specific because so far, capsaicin has been found to affect only nociceptive primary afferents. At the cellular level, capsaicin depolarizes sensory terminals and exerts a Ca2+ dependent SP release in the spinal cord. Capsaicin prolongs sensory neuron action potentials, whereas opiates and opioid peptides shorten AP duration and inhibit SP release from spinal sensory terminals. Capsaicin's hyperpolarization of DRG neurons provides an interesting contrast that indicates differences in its effects on ganglionic, axonal, terminal and receptor sites. Also due to its specific action, capsaicin has been used to indicate presynaptic opiate receptors on SP-releasing spinal nociceptive terminals.

Capsazepine prolongation of the duration of lidocaine block of sensory transmission in mice may be mediated by modulation of HCN channel currents

Capsazepine concentration dependently inhibits currents in HEK 293 cells mediated by human hyperpolarization-activated cyclic nucleotide-gated 2 and 4 channels.

Long-term Potentiation Alters the Modulator Pharmacology of AMPA-type Glutamate Receptors.

Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel.

The effects of Zn2+ on long-term potentiation of C fiber-evoked potentials in the rat spinal dorsal horn

Dexmedetomidine Prolongs Lidocaine Intravenous Regional Anesthesia in Rats by Blocking the Hyperpolarization-Activated Cation Current

Tetrodotoxin, Epinephrine, And Chemical Permeation Enhancer Combinations In Peripheral Nerve Blockade

On the mechanism by which epinephrine potentiates lidocaine's peripheral nerve block

[Vasodilating Effect of Capsaicin on Rat Mesenteric Artery and Its Mechanism].

Population Coding of Capsaicin Concentration by Sensory Neurons Revealed Using Ca2+ Imaging of Dorsal Root Ganglia Explants from Adult pirt-GCaMP3 Mouse.

Time Course of Acute Neuroprotective Effects of Lidocaine Evaluated by Brain Impedanciometry in the Global Ischemia Model

Neurophysiological effects of capsaicin

Amiodarone Provides Long-Lasting Local Anesthesia and Analgesia in Open-State Mouse Nociceptors

Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model

A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers

Capsazepine inhibits mitochondrial transport in cultured hippocampal neuronal networks of rat

Galacturonic acid-capsaicin prodrug for prolonged nociceptive-selective nerve blockade

Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice

Inhibition of Hyperpolarization-Activated Current by ZD7288 Suppresses Ectopic Discharges of Injured Dorsal Root Ganglion Neurons in a Rat Model of Neuropathic Pain

Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion

Depolarizing shift in the GABA-induced current reversal potential by lidocaine hydrochloride